Linvoseltamab-gcpt causes the release of cytokines [see Clinical Pharmacology (12.2) ] that may suppress cytochrome P450 (CYP) enzyme activity .
Source: FDA drug label - linvoseltamab-gcpt
1 interaction on record
Linvoseltamab-gcpt causes the release of cytokines [see Clinical Pharmacology (12.2) ] that may suppress cytochrome P450 (CYP) enzyme activity .
Source: FDA drug label - linvoseltamab-gcpt